InvestorsHub Logo
Followers 104
Posts 4960
Boards Moderated 0
Alias Born 10/20/2015

Re: powerwalker post# 86566

Wednesday, 01/04/2017 12:47:36 AM

Wednesday, January 04, 2017 12:47:36 AM

Post# of 474315
Excellent job of connecting the dots! It seems more likely than not likely there will be some type of Anavex/Biogen tie up. The synergies are just too compelling, with Biogen's focus on CNS and Anavex's Sigma-1 discovery platform possibly framing a new paradigm in that realm.
Do not worry if only a 10X bagger on a buyout, hold the Biogen stock if that is what is given for AVXL shares. Because together Biogen and Anavex would most likely dominate the CNS drug market for decades and so in the coming years Biogen/Anavex combination might be another 5X-10X bagger as the drugs are brought to the market for a number of indications. If it is a partnership instead of buyout (which I would prefer) then maybe initially less of a price surge but a "Blue Sky Tornado" none the less and more to keep for AVXL in the long run.
The stars seem to align on your timeline. Dr. Missling said this morning "a good way start to 2017" as if he was dropping bread crumbs (as he likes to do)as in the German fairytaleHansel and Gretel.
It is conjecture I know, however, the elements of the puzzle lay before us. The timing is right for the data from the MTA study by Biogen, the New Biogen CEO will want to "start with a bang" and AVXL has three big time clinical trials that are just about ready to be "teed up" just waiting for a "big hitter" to join AVXL in the tee box. Sooner or later something will happen. Does Biogen's new CEO take the helm on Thursday so he has time to "Drive the Golden Spike" with AVXL on Friday and announce within two business days to the public as required on Monday at the JPM Health Conference?
I think I will follow the sign posts and connect the dots.
Happy New Year!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News